Rankings
▼
Calendar
BCYC Q2 2021 Earnings — Bicycle Therapeutics plc Revenue & Financial Results | Market Cap Arena
BCYC
Bicycle Therapeutics plc
$360M
Q2 2021 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$2M
+13.6% YoY
Gross Profit
$2M
100.0% margin
Operating Income
-$17M
-967.9% margin
Net Income
-$18M
-1003.5% margin
EPS (Diluted)
$-0.74
QoQ Revenue Growth
-1.3%
Cash Flow
Operating Cash Flow
-$12M
Free Cash Flow
-$13M
Stock-Based Comp.
$3M
Balance Sheet
Total Assets
$226M
Total Liabilities
$84M
Stockholders' Equity
$142M
Cash & Equivalents
$199M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$2M
$2M
+13.6%
Gross Profit
$2M
$2M
+13.6%
Operating Income
-$17M
-$13M
-37.3%
Net Income
-$18M
-$12M
-47.9%
← FY 2021
All Quarters
Q3 2021 →